Sponsor pipeline

Cybin IRL Limited clinical trial pipeline

3 active trials 1 recruiting 3 Phase 3 1 disease areas 2 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-08-28

What changed in the last 30 days

2026-08-13

Enrollment closed, study ongoing

NCT06564818 "A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive… · Phase 3

2026-08-14

Trial completed

NCT06051721 A Study of a N, N-dimethyltryptamine (DMT) Analog (CYB004) in Participants With… · Phase 2

Phase 3

NCT ID	Title	Condition	Status	Updated
Phase 3
NCT06793397	A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder	Major Depressive Disorder (MDD)	Recruiting	2026-08-26
NCT06564818	"A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive…	Major Depressive Disorder	Active, Not Recruiting	2026-08-12
NCT06605105	Phase III Long-term Extension Trial to Assess Safety and Efficacy of CYB003 in MDD…	Major Depressive Disorder	Enrolling by Invitation	2026-07-13

Get alerts when Cybin IRL Limited's trials change

Status changes, date slips, and new filings: detected daily, delivered to your inbox.